AUB
BNGO icon

Atlantic Union Bankshares’s Bionano Genomics BNGO Stock Holding History

Atlantic Union Bankshares’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Buy
+1
New +$1 ﹤0.01% 1748

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Carret Asset Management New York $1.02B AUM 26.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Atlantic Union Bankshares's BNGO Position: Q1 2026 in Review

Atlantic Union Bankshares opened a new position in Bionano Genomics (BNGO) in Q1 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #1748 among its holdings.

32 funds tracked by Wall St. Rank hold BNGO as of Q1 2026.

  • Atlantic Union Bankshares held 1 share of Bionano Genomics worth $1 as of Q1 2026.
  • Bionano Genomics was a new Atlantic Union Bankshares position in Q1 2026.
  • Bionano Genomics made up ﹤0.01% of Atlantic Union Bankshares's portfolio in Q1 2026, its #1748 holding.
  • 32 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2026.

Based on Atlantic Union Bankshares's 13F filing for Q1 2026, filed 12 May 2026.